Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease

NMR in Biomedicine

Volumn 20, Issue 3, 2007, Pages 343-351

  Falangola, M F ^a,b   Dyakin, V V ^a   Lee, S P ^a,c   Bogart, A ^a   Babb, J S ^b   Duff, K ^a,b,d   Nixon, R ^a,b   Helpern, J A ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

amyloid; Alzheimer's disease; Iron; MRI; T2 relaxation time; Transgenic mice

Indexed keywords

ANIMALS; BIOMEDICAL ENGINEERING; COMPUTER SIMULATION; MEDICAL IMAGING; PATHOLOGY; PROTEINS; RELAXATION TIME;

ALZHEIMER'S DISEASE; MOUSE MODELS; NON-TRANSGENIC (NTG) CONTROLS; TRANSGENIC MICE;

MAGNETIC RESONANCE IMAGING;

AMYLOID BETA PROTEIN; PRESENILIN 1; WATER;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GENOTYPE; HIPPOCAMPUS; HISTOPATHOLOGY; IMAGE ANALYSIS; LONGITUDINAL STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REFERENCE VALUE; RELAXATION TIME; TRANSGENIC MOUSE; WILD TYPE;

AGING; ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE IMAGING; MALE; MICE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 34249674880     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1163     Document Type: Article

References (33)

1. Higgins GA, Jacobsen H. Transgenic mouse models of Alzheimer's disease: phenotype and application. Behav Pharmacol 2003; 14(5-6): 419-38.
2. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995; 373(6514): 523-7.
3. Hsiao K, Chapman P, Nielsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole GM. Correlative memory deficits, Aß elevation, and amyloid plaques in transgenic mice. Science 1996; 274: 99-102.
4. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996; 383: 710-713.
5. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998; 4: 97-100.
6. Matsuoka Y, Picciano M, Malester B, LaFrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O'Banion MK, Tenner AJ, Lemere CA, Duff K. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol 2001; 158: 1345-1354.
7. McGowan E, Sanders S, Iwatsubo T, Takeuchi A, Saido T, Zehr C, Yu X, Uljon S, Wang R, Mann D, Dickson D, Duff K. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis 1999; 6: 231-244.
8. Wengenack TM, Whelan S, Curran GL, Duff KE, Poduslo JF. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience 2000; 101(4): 939-944.
9. Tsai J, Grutzendler J, Duff K, Gan WB. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 2004; 7(11): 1181-3.
10. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M, Mann DM, Hyman BT, Iwatsubo T. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 2000; 157: 331-339.
11. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch CA, Wisniewski T, de Leon MJ, Wolf OT, O'Shea J, Nixon RA. In vivo detection of neuropathology in an animal model of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med 2004; 51(4): 794-798.
12. Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA. Histological co-localization of iron in Aß plaques of PS/APP transgenic mice. Neurochem Res 2005; 30: 201-205.
13. El Tannir El Tayara N, Delatour B, Le Cudennec C, Guegan M, Volk A, Dhenain M. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2006; 22(1): 199-208.
14. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CRJ. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 2002; 11: 315-329.
15. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li YS, Scholtzova H, Tang CY, Aguilnaldo JG, Pappolla M, Duff K, Wisniewski T, Turnbull DH. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance micro-imaging. Magn Reson Med 2003; 50: 293-302.
16. Lee SP, Falangola MF, Nixon RA, Duff K, Helpern JA. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn Reson Med 2004; 52(3): 538-44.
17. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G, Grohn OH, Grimm R, Poduslo JF. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 2004; 52(6): 1263-71.
18. Zhang J, Yarowsky P, Gordon MN, Di Carlo G, Munireddy S, van Zijl PC, Mori S. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med 2004; 51(3): 452-7.
19. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V7171] transgenic mice, a model for Alzheimer's disease. Magn Reson Med 2005; 53(3): 607-13.
20. Hock BJ Jr, Bunsey MD. Differential effects of dorsal and ventral hippocampal lesions. J Neurosci 1998; 18(17): 7027-32.
21. Degroot A, Treit D. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Res 2002; 949(1-2): 60-70.
22. Jerman TS, Kesner RP, Lee I, Berman RF. Patterns of hippocampal cell loss based on subregional lesions of the hippocampus. Brain Res 2005; 1065(1-2): 1-7.
23. Kurt MA, Davies DC, Kidd M, Duff K, Rolph SC, Jennings KH, Howlett DR. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp Neurol 2001; 171(1): 59-71.
24. Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, Jensen CH, Duff K, Nixon RA, Gruen RJ, Wisniewski T. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. J Neuropathol Exp Neurol 2004; 63(5): 418-28.
25. McCarthy JV. Involvement of presenilins in cell-survival signalling pathways. Biochem Soc Trans. 2005: 568-72.
26. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, Chattarji S, Kelleher RJ 3rd, Kandel ER, Duff K, Kirkwood A, Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004; 42(1): 23-36.
27. Barrow PA, Empson RM, Gladwell SJ, Anderson CM, Killick R, Yu X, Jefferys JG, Duff K. Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol Dis 2000; 7(2): 119-26.
28. Kadish I, Pradier L, van Groen T. Transgenic mice expressing the human presenilin 1 gene demonstrate enhanced hippocampal reorganization following entorhinal cortex lesions. Brain Res Bull 2002; 57(5): 587-94.
29. Wong TP, Debeir T, Duff K, Cuello AC. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J Neurosci 1999; 19(7): 2706-16.
30. 2: a theoretical and experimental approach. J Cereb Blood Flow Metab 2000; 20: 316-326.
31. Jack CR Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 2005; 25(43): 10041-8.
32. Falangola MF, Lee S-P, Jensen JH, Lu H, Nixon RA, Duff K, Helpern JA. MRI assessment of Aβ-iron complex in PS/APP mouse brain. Proc. Int. Soc. Magn. Reson. Med. 14(2006): 946.
33. Chang L, Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 1996; 58: 2049-2056.